tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

Viking Therapeutics: External Validation and Same-Molecule Strategy De-Risk Obesity Program, Supporting Buy Rating
RatingsViking Therapeutics: External Validation and Same-Molecule Strategy De-Risk Obesity Program, Supporting Buy Rating
11d ago
VKTX
H.C. Wainwright says Lilly’s topline results de-risk Viking oral VK2735 program
PremiumThe Fly
H.C. Wainwright says Lilly’s topline results de-risk Viking oral VK2735 program
11d ago
LLY
VKTX
Crypto Currents: Bitcoin settlement volume flips Visa
PremiumThe Fly
Crypto Currents: Bitcoin settlement volume flips Visa
19d ago
V
MA
Viking Therapeutics call volume above normal and directionally bullish
PremiumThe Fly
Viking Therapeutics call volume above normal and directionally bullish
1M ago
VKTX
Strong Enrollment and Promising Strategy Propel Viking Therapeutics to ‘Buy’ Rating
PremiumRatings
Strong Enrollment and Promising Strategy Propel Viking Therapeutics to ‘Buy’ Rating
1M ago
VKTX
Promising Potential of Viking Therapeutics’ VK2735 Justifies Buy Rating
PremiumRatingsPromising Potential of Viking Therapeutics’ VK2735 Justifies Buy Rating
1M ago
VKTX
Viking Therapeutics completes patient enrollment in VANQUISH-1 clinical trial
Premium
The Fly
Viking Therapeutics completes patient enrollment in VANQUISH-1 clinical trial
1M ago
VKTX
Viking Therapeutics price target raised to $107 from $106 at Canaccord
Premium
The Fly
Viking Therapeutics price target raised to $107 from $106 at Canaccord
2M ago
MTSR
VKTX
Viking Therapeutics’ VK2735: A Promising Step Forward in Metabolic Disease Treatment Justifying a Buy Rating
PremiumRatings
Viking Therapeutics’ VK2735: A Promising Step Forward in Metabolic Disease Treatment Justifying a Buy Rating
2M ago
VKTX
Viking Therapeutics’ VK2735 Trials and Strategic Positioning Drive Buy Rating
PremiumRatings
Viking Therapeutics’ VK2735 Trials and Strategic Positioning Drive Buy Rating
2M ago
VKTX
Promising Potential of Viking Therapeutics’ VK2735: A Buy Rating Justified by Efficacy in Weight Loss and Metabolic Health
PremiumRatings
Promising Potential of Viking Therapeutics’ VK2735: A Buy Rating Justified by Efficacy in Weight Loss and Metabolic Health
2M ago
VKTX
Viking Therapeutics’ VK2735 obesity program shows efficacy in new presentations
PremiumThe Fly
Viking Therapeutics’ VK2735 obesity program shows efficacy in new presentations
2M ago
VKTX
Viking Therapeutics: Strategic Positioning and Growth Potential Justify Buy Rating
PremiumRatingsViking Therapeutics: Strategic Positioning and Growth Potential Justify Buy Rating
2M ago
VKTX
Viking Therapeutics call volume above normal and directionally bullish
Premium
The Fly
Viking Therapeutics call volume above normal and directionally bullish
2M ago
VKTX
Midday Fly By: Nvidia hits $5T market cap, Boeing takes big 777X charge
Premium
The Fly
Midday Fly By: Nvidia hits $5T market cap, Boeing takes big 777X charge
2M ago
BA
FI
Skyworks upgraded, UnitedHealth downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Skyworks upgraded, UnitedHealth downgraded: Wall Street’s top analyst calls
2M ago
EW
SR
Canaccord starts Viking Therapeutics with Buy on obesity potential
PremiumThe Fly
Canaccord starts Viking Therapeutics with Buy on obesity potential
2M ago
VKTX
Viking Therapeutics initiated with a Buy at Canaccord
PremiumThe Fly
Viking Therapeutics initiated with a Buy at Canaccord
2M ago
VKTX
Viking Therapeutics price target lowered to $75 from $80 at JPMorgan
PremiumThe Fly
Viking Therapeutics price target lowered to $75 from $80 at JPMorgan
2M ago
VKTX
Viking Therapeutics Navigates Regulatory Risks Amid U.S. Policy Shifts
PremiumCompany AnnouncementsViking Therapeutics Navigates Regulatory Risks Amid U.S. Policy Shifts
2M ago
VKTX
Viking Therapeutics’ Earnings Call: Clinical Success Amid Financial Challenges
Premium
Company Announcements
Viking Therapeutics’ Earnings Call: Clinical Success Amid Financial Challenges
2M ago
VKTX
Viking Therapeutics price target raised to $102 from $98 at Morgan Stanley
Premium
The Fly
Viking Therapeutics price target raised to $102 from $98 at Morgan Stanley
2M ago
VKTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >